We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| STARSOURCE MULTITRADE LIMITED | 0.21 | -118.05 | NA | -78.70 | 21.3 | 62.6 |
| ZENITH HEALTH CARE LTD. | 33.17 | -0.19 | 31.51 | 0.01 | 20.4 | 292.0 |
| COLINZ LABORATORIES LTD. | 16.41 | 1.19 | 15.66 | 0.54 | 19.4 | 40.5 |
Chemo Pharma Laboratories Ltd.,, with Security Code 506365, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Expenses | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 11.8 |
| Operating Profit | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | -11.8 |
| OPM % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Income | -0.1 | 0.4 | 0.5 | 0.7 | 0.2 | 0.3 | 0.6 | -0.1 | -0.2 | 0.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -0.1 | 0.4 | 0.4 | 0.7 | 0.2 | 0.2 | 0.6 | -0.2 | -0.2 | -11.8 |
| Tax % | -77.5% | 0% | 0% | 0% | -220.4% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.1 | 0.4 | 0.4 | 0.7 | -0.3 | 0.2 | 0.6 | -0.2 | -0.3 | -11.8 |
| EPS in Rs | -0.99 | 12.51 | 2.93 | 4.51 | -1.94 | 1.64 | 4.07 | -1.17 | -2.26 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 41% |
| 3 Years: | 68% |
| TTM: | -70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 78% |
| 3 Years: | 56% |
| 1 Year: | 71% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 78% |
| 3 Years: | 56% |
| 1 Year: | 71% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|